261 related articles for article (PubMed ID: 23549818)
1. Reversible infertility associated with testosterone therapy for symptomatic hypogonadism in infertile couple.
Bang JK; Lim JJ; Choi J; Won HJ; Yoon TK; Hong JY; Park DS; Song SH
Yonsei Med J; 2013 May; 54(3):702-6. PubMed ID: 23549818
[TBL] [Abstract][Full Text] [Related]
2. Misuse of testosterone replacement therapy in men in infertile couples and its influence on infertility treatment.
Song SH; Sung S; Her YS; Oh M; Shin DH; Lee J; Baek J; Lee WS; Kim DS
Clin Exp Reprod Med; 2019 Dec; 46(4):173-177. PubMed ID: 31739658
[TBL] [Abstract][Full Text] [Related]
3. Androgen replacement in men with hypogonadism and erectile dysfunction.
Albrecht-Betancourt M; Hijazi RA; Cunningham GR
Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
[TBL] [Abstract][Full Text] [Related]
4. Current topics in testosterone replacement of hypogonadal men.
Nieschlag E
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
[TBL] [Abstract][Full Text] [Related]
5. Male infertility and gonadotropin treatment: What can we learn from real-world data?
Esteves SC; Achermann APP; Simoni M; Santi D; Casarini L
Best Pract Res Clin Obstet Gynaecol; 2023 Feb; 86():102310. PubMed ID: 36682942
[TBL] [Abstract][Full Text] [Related]
6. [Choice of treatment of erectile dysfunction associated with hypogonadism].
Aliaev IuG; Vinarov AZ; Akhvlediani ND
Urologiia; 2010; (4):37-8, 40-2. PubMed ID: 20967981
[TBL] [Abstract][Full Text] [Related]
7. Sperm Count and Hypogonadism as Markers of General Male Health.
Ferlin A; Garolla A; Ghezzi M; Selice R; Palego P; Caretta N; Di Mambro A; Valente U; De Rocco Ponce M; Dipresa S; Sartori L; Plebani M; Foresta C
Eur Urol Focus; 2021 Jan; 7(1):205-213. PubMed ID: 31427194
[TBL] [Abstract][Full Text] [Related]
8. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism.
Kaminetsky JC; Moclair B; Hemani M; Sand M
J Sex Med; 2011 Apr; 8(4):1186-96. PubMed ID: 21269402
[TBL] [Abstract][Full Text] [Related]
9. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men.
Zitzmann M; Mattern A; Hanisch J; Gooren L; Jones H; Maggi M
J Sex Med; 2013 Feb; 10(2):579-88. PubMed ID: 22812645
[TBL] [Abstract][Full Text] [Related]
10. Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia.
Vandekerckhove P; Lilford R; Vail A; Hughes E
Cochrane Database Syst Rev; 2000; 1996(2):CD000150. PubMed ID: 10796496
[TBL] [Abstract][Full Text] [Related]
11. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
12. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
13. Hormonal therapy of male hypogonadism.
Matsumoto AM
Endocrinol Metab Clin North Am; 1994 Dec; 23(4):857-75. PubMed ID: 7705324
[TBL] [Abstract][Full Text] [Related]
14. Cryptozoospermia after treatment with clomiphene citrate following long-term use of intramuscular testosterone undecanoate depot injection (Nebido®).
Grubić Kezele T
Horm Mol Biol Clin Investig; 2019 Mar; 39(2):. PubMed ID: 30870141
[TBL] [Abstract][Full Text] [Related]
15. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and Male Infertility.
Ohlander SJ; Lindgren MC; Lipshultz LI
Urol Clin North Am; 2016 May; 43(2):195-202. PubMed ID: 27132576
[TBL] [Abstract][Full Text] [Related]
17. Testosterone undecanoate in the treatment of male hypogonadism.
Edelstein D; Basaria S
Expert Opin Pharmacother; 2010 Aug; 11(12):2095-106. PubMed ID: 20642374
[TBL] [Abstract][Full Text] [Related]
18. Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy.
Kohn TP; Louis MR; Pickett SM; Lindgren MC; Kohn JR; Pastuszak AW; Lipshultz LI
Fertil Steril; 2017 Feb; 107(2):351-357.e1. PubMed ID: 27855957
[TBL] [Abstract][Full Text] [Related]
19. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life.
Yassin DJ; Doros G; Hammerer PG; Yassin AA
J Sex Med; 2014 Jun; 11(6):1567-76. PubMed ID: 24712761
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of testosterone undecanoate (Nebido(®)) in testosterone deficiency syndrome in Korean: a multicenter prospective study.
Moon DG; Park MG; Lee SW; Park K; Park JK; Kim SW; Park NC; Ahn TY; Paick JS; Seo JT; Yang DY; Lee JY; Kim JJ
J Sex Med; 2010 Jun; 7(6):2253-2260. PubMed ID: 20345732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
